
News
Advertisement


Advertisement




Advertisement




Advertisement

Lyme disease, if not treated promptly with antibiotics, can become a lingering problem for those infected. But a new study led by researchers from the University of Pennsylvania has some brighter news: Once infected with a particular strain of the disease-causing bacteria, humans appear to develop immunity against that strain that can last six to nine years.

















An international research group led by Arizona State University professor Qiang Chen has developed a new generation of potentially safer and more cost-effective therapeutics against West Nile virus and other pathogens.


Advertisement
Advertisement
Trending on Infection Control Today
1
Hantavirus Concerns and Cruise Ship Hygiene: What Infection Preventionists Need to Know
2
Education, Advocacy, and Recognition: Malinda Elammari on the Future of Sterile Processing
3
IP LifeLine: Connecting With Specialized Recruiters and Navigating the Hiring Process
4